GlassScriptPhysician profile
Thiru V Lakshman
NPI 1427187350
$755,571.97
in general payments reported to CMS, 2019-2025
34 companies · $105K in 2025
The $105K reported for 2025 was more than what 99% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174K · 2020: $93K · 2021: $111K · 2022: $106K · 2023: $71K · 2024: $95K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $164K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56K · Travel and Lodging: $44K · Food and Beverage: $6,024 · Honoraria: $1,000 · Gift: $59.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $163,640.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,500.00 |
| Travel and Lodging | $44,050.85 |
| Food and Beverage | $6,024.44 |
| Honoraria | $1,000.00 |
| Gift | $59.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $750,930.14 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Pfizer INC. | $1,056.00 | 2025 | |
| Zyla Life Sciences, INC. | $587.80 | 2019-2020 | |
| Medtronic, INC. | $421.50 | 2021-2025 | Interstim, Signia |
| Integra Lifesciences Corporation | $290.05 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Davol INC. | $275.94 | 2019-2025 | Phasix Mesh |
| Tela Bio, INC. | $247.21 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Thd America, INC. | $191.79 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.41 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $165.74 | 2021-2023 | Gattex |
| Axonics, INC. | $158.21 | 2020-2022 | |
| Conmed Corporation | $139.37 | 2019-2022 | |
| Ethicon US, LLC | $137.91 | 2019-2025 | Vistaseal, Ethicon |
| Redhill Biopharma INC. | $137.60 | 2021 | |
| Covidien LP | $94.66 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $61.66 | 2019-2020 | |
| Baxter Healthcare | $61.63 | 2020-2021 | |
| Shire North American Group INC | $54.78 | 2019 | |
| Innovation Technologies INC | $47.00 | 2022-2024 | Irrisept |
| Mimedx Group, INC. | $37.81 | 2025 | |
| Hologic Sales and Service, LLC | $36.44 | 2025 | Coolseal Generator |
| Heron Therapeutics, INC. | $35.67 | 2022 | |
| Boston Scientific Corporation | $33.36 | 2020 | |
| Kerecis Limited | $28.69 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Dilon Technologies, INC. | $28.05 | 2024 | Hemoblast Bellows |
| Tempus Ai, INC | $23.00 | 2025 | Xt Cdx |
| Edwards Lifesciences Corporation | $21.52 | 2020 | |
| Cook Medical LLC | $20.25 | 2019 | |
| Medspira, LLC | $19.94 | 2022 | |
| Baudax Bio INC. | $16.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.36 | 2020 | |
| Braintree Laboratories, INC. | $13.09 | 2019 | |
| Acell, INC. | $10.46 | 2019 | |
| Romark Laboratories, Lc | $6.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thiru Lakshman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.